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Diagnostic cardiac catheterization and percutaneous coro-
nary interventions (PCIs) are critical components of the
diagnosis and treatment of patients with coronary artery
disease. As the prevalence of heart disease increases in our
aging population and increasingly aggressive invasive ap-
proaches are developed for the treatment of coronary artery
disease, the number of cardiac catheterization procedures
performed yearly continues to rise. In the U.S., an estimated
1,194,000 in-patient cardiac catheterizations were per-
formed in 1997 along with nearly 500,000 PCIs (1).
Since Andreas Gruentzig performed the first human
angioplasty, PCI has rapidly evolved to be a highly success-
ful strategy for achieving myocardial revascularization in
patients with coronary artery disease. The PCI mortality
rate has decreased in the present era to a fraction of 1%. The
number of PCI procedure-related complications leading to
myocardial infarction or emergent coronary artery bypass
graft surgery has decreased considerably to fewer than 3%
each (2). Intracoronary stenting with PCI has taken center
stage at the end of the second decade of interventional
cardiology. Between 1993 and 1997, stents became common-
place, leading to improved procedural success rates, decreased
in-hospital complication rates, and decreased restenosis rates.
With the advent of new devices and pharmacological therapies,
the risk of adverse outcomes associated with PCI has further
decreased. Procedural success rates and complication rates of
conventional balloon angioplasty have improved with the
introduction of directional coronary atherectomy, rotational
atherectomy, extraction atherectomy, and other so-called niche
catheter devices. New catheter devices such as filter systems
and distal occlusion/aspiration systems are now being intro-
duced. These devices help to minimize periprocedural myo-
cardial infarctions that occur during PCI performed in diseased
saphenous vein grafts associated with the release of embolic
debris distally in the coronary vasculature. The major drawback
of PCI, an unacceptable restenosis rate, is presently being
approached with newly developing treatments such as coronary
brachytherapy and the use of chemotherapy-eluting stents.
For more than 24 years, large-scale registries and data-
bases have been used to accumulate data on PCI and, to a
lesser extent, cardiac catheterizations (3). These registries
have been used to study patient and procedural character-
istics, post-procedure treatments, immediate in-hospital
outcomes, and long-term outcomes. Many different analyses
of these data have been performed in an effort to improve
the quality of care that coronary patients receive. Quality
improvements have come about primarily through a greater
understanding of the risks and benefits of PCI, both globally
for given patient populations and individually for patient
procedure risk stratification. This effort has been critical for
the original balloon angioplasty procedure and more impor-
tantly for the introduction of new devices and the role of
PCI in myocardial infarction.
HISTORICAL DEVELOPMENT OF THE ACC-NCDR™
Among the greatest challenges of cardiovascular data anal-
ysis are the frequency of changing treatments, confusing
terminology, nonstandard definitions, and the lack of ap-
plied data standards. Although some commonality of lan-
guage existed, it had not been formal or rigorous. Recog-
nizing these challenges as an opportunity for professional
society leadership and guidance, the American College of
Cardiology (ACC) set out in 1987 to create a database to
standardize what and how information was collected for
patients receiving cardiac catheterizations and PCI. This
ACC initiative began with the formation of a Database
Committee under the leadership of Suzanne B. Knoebel,
MD, FACC. The committee explored various strategies for
improving the collection and evaluation of cardiovascular
data. As a result, in 1990 the ACC pursued a venture with
Summit Medical Systems, Inc to distribute software that
would electronically manage the collection of 411 ACC core
data elements with annual data harvests to their central
repository. A full description of the historical development
of the ACC-NCDR™ is presented elsewhere (4). From
1991 to 1996, the ACC Data Registry and Summit Medical
Systems, Inc., enrolled more than 300 hospitals and col-
lected data on more than 301,125 cardiac catheterizations
and 166,082 PCIs. The first report of aggregated data from
1991 through January 1996 was reported in late 1996.
Creation of the First Data Set: Cath Lab Module Version 1.1
In planning the original data set, the Database Committee
and its Interventional Subcommittee specified that periodic
revisions would be required as clinical practices changed and
new information became available. In 1994, the ACC
Database Committee pursued an updated version of the
original catheterization laboratory core data elements that were
scientifically valid and feasible in practice. This project, which
soon became an integrated series of related projects, began the
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arduous process of identifying which clinical variables were
needed to properly characterize patients, and then developing
definitions and data standards that could be used to collect and
analyze these variables in a rigorous manner.
In 1997, under the leadership of William S. Weintraub,
MD, FACC, the ACC Board of Trustees approved Cath
Lab Module version 1.1 (v1.1), with data collection begin-
ning in November 1998 by approximately 150 U.S. hospi-
tals. Cath Lab Module v1.1 consists of 141 core data
elements with standard definitions that focus on adult
patients seen in cardiac catheterization laboratories who
were undergoing diagnostic catheterization and/or PCI.
This Cath Lab Module is oriented around patients rather
than procedures. It allows longitudinal tracking and gives
participants a way to monitor the impact of specific proce-
dures over time or to examine the effect of multiple
procedures performed on a single patient.
At the same time, the Board of Trustees approved several
important strategic decisions that would propel the ACC
into a new age of clinical information warehousing by
drastically increasing the support and services provided to
hospitals collecting and submitting clinical data. This was
accomplished by the following steps:
1. Establishing the National Cardiovascular Data Regis-
try™ (ACC-NCDR™), which would be housed at the
Heart House, Bethesda, MD (ACC headquarters);
2. Allowing ACC software certification open to all viable
and committed commercial vendors;
3. Hiring clinically trained personnel to support and recruit
ACC-NCDR™ participants;
4. Using the ACC-NCDR™ as a data processing and data
quality feedback facility;
5. Increasing the frequency of participant data submissions
from annually to quarterly, allowing for more timely report-
ing.
In November 1998, all previous ACC Data Registry par-
ticipants were required to re-enroll with the ACC-
NCDR™, of which 75 did by December 1998. Approxi-
mately five new software vendors obtained ACC software
certification. Simultaneously, Summit Medical Systems,
Inc., announced it was no longer planning to provide clinical
registry software products and support. Since the launch of
the ACC-NCDR™, participant enrollment and vendor
software certifications have continued to grow, with a
current total of more than 350 enrolled participants and 16
certified software vendors.
The Big Revision: Cath Lab Module v2.0b
New technologies and scientific evidence in the catheteriza-
tion laboratory during the past two years created the need
for the ACC to update v1.1. After nearly a year of diligent
planning and review, members of the Interventional Sub-
committee of the ACC-NCDR™, led by H. Vernon
Anderson, MD, FACC, with feedback from ACC-
NCDR™ participants on the needs and clarity of specific
data elements and definitions, completed the successful
revision of the Cath Lab Module to version 2.0b (v2.0b)
(Table 1). The Cath Lab Module v1.1 revision process was
an arduous one because of the charge for the Interventional
Subcommittee to have a focus and a vision to include data
elements that met the following goals:
c Linkage to recommendations from the ACC/American
Heart Association (AHA) Clinical Practice Guidelines,
as well as anticipated Joint Commission for Accreditation
of Healthcare Organizations (JCAHO) core measures to
track performance measures and assess clinical outcomes.
c Consistency with other national and regional cardiovas-
cular registries, such as the Society for Thoracic Surgeons
(STS) National Data Registry, Society for Coronary
Angiography and Interventions, Northern New England
Cardiovascular Study Group, and National Cardiovascu-
lar Network. Of the 142 data elements in v2.0b, 43
definitions were mapped to the STS database, and up to
69 mapped to 4 other nationally recognized registries.
c Incorporation of the recently approved definition of a
myocardial infarction (5).
c Inclusion of new categories to reflect recent catheteriza-
tion laboratory developments, such as percutaneous clo-
sure devices and newer “niche” catheters.
c Inclusion of long-term outcomes data elements to allow
assessment of the patient’s clinical course after discharge
from the catheterization laboratory.
Some of these modifications resulted from the growing use
of glycoprotein IIb/IIIa inhibitors, increased use of stents,
and the introduction of groin closure devices. Additionally,
our early experience with v1.1 revealed problems with some
of the data definitions (for example, the definitions of
unstable angina and non–Q-wave myocardial infarction in
the new era of troponin measurement). In-depth compari-
sons exposed discrepancies between v1.1 and other large
databases. In addition, the ACC had recognized that
development of practice guidelines and performance mea-
sures was a legitimate and necessary effort for professional
societies to undertake to aid clinicians in promoting quality
of care. The ACC-NCDR™ Cath Lab 2.0b Module was
created to become a key component in collecting data
elements to track such performance and outcome measures
related to the catheterization laboratory.
The resulting Cath Lab Module v2.0b was approved by
the ACC-NCDR™ Planning and Management Task Force
Table 1. Key Enhancements in Version 2.0
c Cardiac status—Measurement of acute coronary syndrome, angina
type, and noninvasive testing.
c Adverse outcomes—Periprocedural myocardial infarction and
recording of CK-MB levels, as well as capturing contrast reactions.
c Performance measures—Door-to-balloon/stent deployment time and
closure devices.
c Optional follow-up elements—Vital status (alive or died, with primary
cause of death), as well as readmission (including reason for
readmission).
2241JACC Vol. 37, No. 8, 2001 Brindis et al.
June 15, 2001:2240–5 ACC-NCDR™
in March 2000. ACC-NCDR™ software vendors received
v2.0 in April 2000, and participants received v2.0 in June
2000. To facilitate the transition to Cath Lab Module v2.0,
the ACC-NCDR™ conducted two educational workshops
for participants on the new data elements and definitions in
October 2000. More than 180 ACC-NCDR™ participants
and ACC certified software vendors attended the two-day
workshop to learn how v2.0 was created and how it can be
used for outcomes analysis, risk adjustment, and quality
improvement. Additionally, attendees participated in several
practice coding sessions that incorporated v2.0 definitions.
OPERATIONALIZING THE ACC-NCDR™
The main objective of the ACC-NCDR™ is to become the
most comprehensive comparative database for both in-
patient and out-patient cardiovascular care available in the
U.S. Since institutions began enrollment in the ACC-
NCDR™ in November 1998, it has grown to represent 350
participants (hospitals, free-standing laboratories, and adult
cardiology practices) (Fig. 1).
In addition several international cardiology societies have
begun to adopt the standards and definitions included in the
Cath Lab Module v2.0. The ACC is also planning to open
ACC-NCDR™ enrollment to members of the interna-
tional cardiology community.
ACC-NCDR™ Contracted Software Products
The ACC-NCDR™ contracts with commercial software
vendors who have agreed to provide certified software
(adhering to ACC clinical and coding data standards) to
interested institutions. Participating institutions obtain cer-
tified software that allows them to systematically collect data
about care provided to patients undergoing diagnostic car-
diac catheterization or PCIs. After obtaining certified soft-
ware, participants are able to submit data to the ACC-
NCDR™ (Fig. 2).
Participants receive quarterly Call for Data letters that
describe in detail the process for submitting data to the
ACC-NCDR™. Data are exported via certified software and
either e-mailed or mailed to the ACC-NCDR™. The data-
base uses encrypted identifiers, a system that preserves patient
and physician confidentiality while permitting a longitudinal,
patient-oriented view of the data. In addition, data are ware-
housed in a secure information system at the ACC.
ENSURING QUALITY DATA
Since 1998, the ACC-NCDR™ has received data on more
than 414,000 admissions, 354,754 cardiac catheterizations,
and 169,098 PCIs from institutions of various sizes and
geographic locations, including both urban and rural set-
tings, that are representative of both community and aca-
demic sites within the U.S. (Fig. 3). The ACC-NCDR™
uses a number of educational opportunities to ensure the
quality of these data such as annual user group meetings,
participant workshops, a participant training manual, news-
letters, clinical support staff, and plans for future auditing.
Figure 1. Cumulative enrollment by month. Figure 2. ACC-NCDR™ working relationships.
Figure 3. Total patient counts by submission period. Total admissions 5
414,693; total cardiac caths 5 354,754, total percutaneous coronary
interventions (PCIs) 5 169,098; Q 5 quarter.
2242 Brindis et al. JACC Vol. 37, No. 8, 2001
ACC-NCDR™ June 15, 2001:2240–5
Participants have used the ACC-NCDR™ to facilitate
quality improvement activities and to provide national
comparative data benchmarks. The most recent annual user
group meeting was held in March 2001, with more than 180
attendees who presented oral and poster presentations on
local cardiovascular quality improvement initiatives and
efficient data collection systems.
The most important component of the data quality check
and improvement process is the Data Quality Report
(DQR), which is sent to participants after each data
submission. The DQR provides feedback on the overall
quality of the data submission and is used as a tool to help
participants prioritize data cleaning efforts before they
resubmit data. The DQR is composed of three distinct
sections: 1) Inclusion Threshold Report; 2) Date Validation
Report; and 3) Data Consistency Report.
Under the leadership of Dr. Richard Shaw, Chair of the
Outcomes Subcommittee, inclusion thresholds were devel-
oped and implemented in 1999 to ensure data reported for
the ACC-NCDR™ were complete and consistent. The
Inclusion Threshold Report is based on select inclusion
categories that represent core data elements that are critical
for analysis of the following: Risk-adjusted mortality and
patient outcomes; performance measures; outcomes analy-
sis; patient demographics; and procedure description.
Threshold values for core data elements vary, ranging
from 95% to 100%, depending on the category identified.
For example, the threshold value for the core data element
“discharge status (alive or expired)” is 100%. In other words,
100% of the patients in a data submission must include a
valid (alive or dead) answer for this data element. If this
element is left blank, the error is displayed in the DQR.
The Date Validation Report selects patient records that
could contain a data entry error in the date fields. Such
errors would affect the statistics calculated for age, post-
procedure length of stay, and total length of stay.
The Data Consistency Report offers the participant
overall information about the number of records in a data
submission that were submitted compared with the number
of records that were loaded into the ACC-NCDR™.
The ACC-NCDR™ began distributing the threshold
component of the DQR in the fall of 1999, and the percent
of data submissions meeting the threshold increased from
37% for data submissions in 1998 to 90% for data submis-
sions in the fourth quarter of 2000 (Fig. 4).
Reports
Institutional reports are published for all enrolled partici-
pants on a quarterly and annual basis. These confidential
reports compare each institution’s outcomes, including risk-
adjusted mortality, with the overall experience of the regis-
try. A comparison group option (selected by each partici-
pant, e.g., all teaching hospitals or a regional hospital
comparison) is being developed for upcoming reports. In
each institutional report, data are displayed for patients
undergoing diagnostic cardiac catheterizations and PCI.
The profile, which focuses on PCI, presents adverse out-
comes for all PCI patients and those with and without acute
myocardial infarction. Additionally, adverse outcomes are
stratified for patients with and without coronary artery
bypass surgery during the same hospitalization.
PUBLICATION AND
PRESENTATION OF ACC-NCDR™ DATA
The ACC presented more than 10 abstracts from 1999 to
2000 at national scientific meetings (AHA, ACC, and
AHA/ACC Scientific Quality Forums) and plans for 10
more abstract submissions and 2 manuscript publications
over the next 12 months. These activities will be facilitated
by the Publications Development Subcommittee, co-
chaired by John F. Williams, MD, MACC, and Ralph G.
Brindis, MD, MPH, FACC. The ACC will also examine
an overall access and use policy that would make aggregate
ACC-NCDR™ data available to ACC members.
THE FUTURE OF THE ACC-NCDR™
The ACC-NCDR™ continues to strategically align itself
with societies such as the STS, National Cardiovascular
Network, and the Society for Coronary Angiography and
Intervention, which share similar goals of using quality data
to measure and improve patient care and outcomes. Impor-
tantly, the ACC-NCDR™ and STS continue to work
closely to incorporate accepted data standards that allow for
less redundant data collection for those who participate in
both registries. Standardized definitions of individual data
elements enable accurate comparisons to be made both for
research purposes and for quality-of-care analysis. The
ACC-NCDR™ will become an integral component of the
catheterization laboratory continuous quality improvement
(CQI) tool kit now being developed under the auspices of
the ACC. Performance and outcomes measures collected
through the ACC-NCDR™ will offer valuable data for
application and use in the creation of future updates of
ACC/AHA guidelines related to catheterization, PCI,
acute myocardial infarction, unstable angina/non–ST-
Figure 4. Data submissions meeting inclusion criteria. Q 5 quarter.
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elevation myocardial infarction. The ACC-NCDR™ po-
tentially will assist ACC advocacy efforts in the promotion
of improvements in individual physician catheterization
laboratory performance, supporting catheterization labora-
tory certification and physician recredentialing.
The ACC-NCDR™ is also considering the introduction
of additional modules for conditions such as acute coronary
syndromes, heart failure, and atrial fibrillation in upcoming
years. Copies of the data elements and definitions for Cath
Lab Module v1.1 and v2.0b can be downloaded from the
ACC-NCDR™ Web site (www.acc.org).
In summary, the ACC-NCDR™ has made significant
strides in collecting and reporting meaningful and complete
diagnostic catheterization and PCI patient data. The ACC-
NCDR™ continues to be a leader in the quest to capture
quality catheterization laboratory data in 2001 and beyond
and is the most comprehensive comparative database for
diagnostic catheterization and PCI in the U.S.
For more information on the ACC-NCDR™, visit
www.acc.org, send an e-mail message to ncdr@acc.org, or
call 800-253-4636, extension 451.
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APPENDIX 1. ACC-NCDR™ CARDIAC CATH LAB MODULE VERSION 2.0B ELEMENT LIST
ADMINISTRATIVE
1 Transmission Number
2 Software Vendor
3 Software Version
4 NCDR Version
5 Participant ID
6 Participant Name
DEMOGRAPHICS
7 Unique Patient ID
8 Patient Last Name
9 Patient First Name
10 Patient Middle Initial
11 Patient SSN/Country Code
12 Gender
13 Race
14 Patient DOB
ADMISSION/DISCHARGE
15 Date of Admission
16 Date of Discharge
17 Admission Status
18 Insurance Payor
19 Number of PCI Lab Visits
20 Multiple PCI—Same Lesion
21 CABG During this Admission—Status
22 CABG During this Admission—Date
23 Discharge Status
24 Date of Death
25 Primary Cause of Death
26 Location of Death
HISTORY AND RISK FACTORS
27 Height
28 Weight
29 Family History of CAD
30 CHF
31 Diabetes
32 Renal Failure
33 Chronic Lung Disease
34 Cerebrovascular Disease
35 Peripheral Vascular Disease
36 Previous MI
37 Hypertension
38 Smoking History
39 Hypercholesterolemia
PREVIOUS INTERVENTIONS
40 Previous PCI
41 Previous PCI—Date
42 Previous CABG
43 Previous CABG—Date
44 Previous Valvular Surgery
45 Previous Valvular Surgery—Date
CARDIAC STATUS
46 CHF—Prior Procedure
47 NYHA
48 Noninvasive Test—Ischemia
49 Angina Type
50 Canadian Clinical Classification
51 ACS Time Period
CATH LAB VISIT
52 Date of Procedure
53 Procedure Number
54 Procedure Type
55 Fluoroscopy Time (min)
56 Cath/PCI Same Lab Visit
CATH LAB VISIT—MEDICATIONS
57 Thrombolytics
58 IIb/IIIa Blockade
59 Heparin
60 Aspirin
61 Clopidogrel/Ticlopidine
CATH LAB VISIT—HEMODYNAMIC
SUPPORT
62 IABP
63 Cardiopulmonary Bypass
CATH LAB VISIT—LV STATUS
64 Left Ventriculogram
65 Left Ventricular Wall Motion
CATH LAB VISIT—EF STATUS
66 EF Testing
67 Ejection Fraction Percent
CATH LAB VISIT—CORONARY ANATOMY
68 Dominance
69 Stenosis Percent—LM
70 Stenosis Percent—Proximal LAD
71 Stenosis Percent—Mid/Distal LAD
72 Stenosis Percent—RCA/PDA if Right or MI
Dominant
73 Stenosis Percent—CIRC
CATH LAB VISIT—PERCUTANEOUS ENTRY
74 Percutaneous Entry Location
75 Closure Device
DIAGNOSTIC CATH PROCEDURE
76 Catheterization Operator’s Name
77 Catheterization Operator’s SSN
78 Cardiac Cath Status
DIAGNOSTIC CATH
PROCEDURE—INDICATIONS
79 Cardiogenic Shock
80 Valvular Heart Disease
81 Arrhythmia
82 Ischemic Heart Disease
83 Positive Functional Tests
84 Heart Disease of Other Etiology
DIAGNOSTIC CATH
PROCEDURE—FINDINGS
85 Pulmonary Hypertension
86 Valve Disease—Mitral
87 Valve Disease—Tricuspid
88 Valve Disease—Aortic
89 Valve Disease—Pulmonic
PCI PROCEDURE
90 PCI Primary Operator’s Name
91 PCI Operator’s SSN
92 PCI Status
PCI PROCEDURE—INDICATIONS
93 Coronary Lesion $50% in a Major Artery
94 Acute MI Present
95 ST Elevation Onset
96 Balloon/Stent Deployment Time
97 Cardiogenic Shock Indication
PCI PROCEDURE—SUMMARY
98 Number of Lesions Attempted
99 Number of Lesions Successfully Dilated
100 Procedure Result
PCI PROCEDURE—LESION
INFORMATION
101 Lesion Identification Number
102 Segment Number
103 Guidewire
104 Pre-Stenosis Percent
105 Post-Stenosis Percent
106 Pre-Procedure TIMI Flow
107 Post-Procedure TIMI Flow
108 Previously Dilated Lesion
109 In Graft to Cited Segment
110 Location in Graft
111 Lesion Risk
112 Device Number
113 Intracoronary Devices Used
114 Primary Intracoronary Device Indicator
115 Dissection in Segment
116 Acute Closure
117 Successful Reopening
118 Perforation
ADVERSE OUTCOMES
119 Periprocedural MI
120 CK-MB ULN
121 CK-MB Baseline
122 CK-MB Peak
123 Cardiogenic Shock
124 Arrhythmia
125 CVA/Stroke
126 Tamponade
127 Vascular Complications—Bleeding
128 Vascular Complications—Occlusion
129 Vascular Complications—Loss of Distal
Pulse
130 Vascular Complications—Dissection
131 Vascular Complications—Pseudoaneurysm
132 Vascular Complications—AV Fistula
133 Contrast Reaction
134 Congestive Heart Failure
135 Renal Failure
136 Emergency PCI
137 Unplanned CABG
OPTIONAL PCI FOLLOW-UP
138 Date of Follow-Up
139 Vital Status
140 Primary Cause of Death
141 Readmission
142 Readmission Reason
2245JACC Vol. 37, No. 8, 2001 Brindis et al.
June 15, 2001:2240–5 ACC-NCDR™
